ATLAS / Macro Radar / Reporting / RLMD

RELMADA THERAPEUTICS, INC. (RLMD) reporting calendar

RELMADA THERAPEUTICS, INC. files periodic reports with the SEC as RLMD on Nasdaq. Atlas tracks 51 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
18 Jul 2026 – 4 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
51

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 42 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open RLMD market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001213900-26-055059
10-K31 Dec 202519 Mar 202678 days0001213900-26-031862
10-Q30 Sep 202513 Nov 202544 days0001213900-25-109983
10-Q30 Jun 20257 Aug 202538 days0001213900-25-073073
10-Q31 Mar 202512 May 202542 days0001213900-25-042025
10-K31 Dec 202427 Mar 202586 days0001013762-25-003426
10-Q30 Sep 20247 Nov 202438 days0001213900-24-095398
10-Q30 Jun 20247 Aug 202438 days0001213900-24-066111
10-Q31 Mar 20248 May 202438 days0001213900-24-040856
10-K31 Dec 202319 Mar 202479 days0001213900-24-024013
10-Q30 Sep 20238 Nov 202339 days0001213900-23-084737
10-Q30 Jun 20238 Aug 202339 days0001213900-23-064519
10-Q31 Mar 202311 May 202341 days0001213900-23-038533
10-K31 Dec 202223 Mar 202382 days0001213900-23-022463
10-Q30 Sep 202210 Nov 202241 days0001213900-22-071154
10-Q30 Jun 202211 Aug 202242 days0001213900-22-046934
10-Q31 Mar 20225 May 202235 days0001213900-22-024229
10-K31 Dec 202125 Mar 202284 days0001213900-22-015012
10-Q30 Sep 202112 Nov 202143 days0001213900-21-058454
10-Q30 Jun 202110 Aug 202141 days0001213900-21-041369
10-Q31 Mar 202112 May 202142 days0001213900-21-025786
10-K31 Dec 202024 Mar 202183 days0001213900-21-017556
10-Q30 Sep 202012 Nov 202043 days0001213900-20-036542
10-Q30 Jun 202012 Aug 202043 days0001213900-20-021649
10-Q31 Mar 202015 May 202045 days0001213900-20-012693
10-Q30 Sep 201913 Nov 201944 days0001213900-19-023219
10-K30 Jun 201924 Sep 201986 days0001213900-19-018787
10-Q31 Mar 201915 May 201945 days0001213900-19-008633
10-Q31 Dec 201813 Feb 201944 days0001213900-19-002391
10-Q30 Sep 201813 Nov 201844 days0001213900-18-015476
10-K30 Jun 201828 Sep 201890 days0001213900-18-013238
10-Q31 Mar 201814 May 201844 days0001213900-18-006121
10-Q31 Dec 201712 Feb 201843 days0001213900-18-001597
10-Q30 Sep 201714 Nov 201745 days0001213900-17-012121
10-K30 Jun 201728 Sep 201790 days0001213900-17-010097
10-Q31 Mar 201715 May 201745 days0001213900-17-005185
10-Q31 Dec 201610 Feb 201741 days0001213900-17-001191
10-Q30 Sep 201610 Nov 201641 days0001213900-16-018211
10-K30 Jun 20169 Sep 201671 days0001213900-16-016664
10-Q31 Mar 20169 May 201639 days0001213900-16-013088

Source: SEC EDGAR company submissions for CIK 0001553643. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.